Tolerance to Trypanosomatids: A Threat, or a Key for Disease Elimination?

Trends in Parasitology

Volumn 32, Issue 2, 2016, Pages 157-168

  Berthier, David ^a   Brenière, Simone F ^a   Bras Gonçalves, Rachel ^a   Lemesre, Jean Loup ^a   Jamonneau, Vincent ^b,c   Solano, Philippe ^a   Lejon, Veerle ^a   Thévenon, Sophie ^a   Bucheton, Bruno ^a,d  

^a Institut de recherche pour le développement   (France)

^b CIRDES Bobo Dioulasso 01 BP 454 ^*  (Burkina Faso)

^c IPR   (South Africa)

^d PNLTHA   (Guinea)

Author keywords

Asymptomatic; Elimination; Leishmaniasis; Trypanosomatids; Trypanosomiasis; Trypanotolerance

Indexed keywords

AFRICAN TRYPANOSOMIASIS; CHAGAS DISEASE; DISEASE ELIMINATION; HUMAN; LEISHMANIASIS; NAGANA; NONHUMAN; REVIEW; TRYPANOSOMATIDAE; VISCERAL LEISHMANIASIS; ANIMAL; DISEASE ERADICATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PHYSIOLOGY; TRYPANOSOMA; TRYPANOSOMIASIS, AFRICAN;

ANIMALS; CHAGAS DISEASE; DISEASE ERADICATION; HUMANS; IMMUNE TOLERANCE; LEISHMANIASIS; TRYPANOSOMA; TRYPANOSOMIASIS, AFRICAN;

EID: 84959167958     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2015.11.001     Document Type: Review

References (100)

1. Murray M., et al. Genetic resistance to African trypanosomiasis. J. Infect. Dis. 1984, 149:311-319.
2. d'Ieteren G.D.M., et al. Trypanotolerance, an option for sustainable livestock production in areas at risk from trypanosomosis. Rev. Sci. Tech. 1998, 17:154-175.
3. Pierre C. L'élevage dans l'Afrique Occiedentale Française 1906, Chalamel.
4. Murray M., et al. Trypanotolerance in cattle and prospects for the control of trypanosomiasis by selective breeding. Rev. Sci. Tech. 1990, 9:369-386.
5. Gibson J.P., Bishop S.C. Use of molecular markers to enhance resistance of livestock to disease: a global approach. Rev. Sci. Tech. 2005, 24:343-353.
6. Chandler R.L. Studies of the tolerance of N'dama cattle to trypanosomiasis. J. Comp. Pathol. 1958, 68:253-260.
7. Roberts C.J., Gray A.R. Studies on trypanosome-resistant cattle. II. The effect of trypanosomiasis on N'dama, Muturu and Zebu cattle. Trop. Anim. Health Prod. 1973, 5:220-233.
8. Paling R.W., et al. Susceptibility of N'Dama and Boran cattle to sequential challenges with tsetse-transmitted clones of Trypanosoma congolense. Parasite Immunol. 1991, 13:427-445.
9. Berthier D., et al. A comparison of phenotypic traits related to trypanotolerance in five West African cattle breeds highlights the value of shorthorn taurine breeds. PLoS ONE 2015, 10:e0126498.
10. Roelants G.E., et al. Trypanotolerance. An individual not a breed character. Acta Trop. 1983, 40:99-104.
11. Freeman A.R., et al. Admixture and diversity in West African cattle populations. Mol. Ecol. 2004, 13:3477-3487.
12. Flori L., et al. Adaptive admixture in the West African bovine hybrid zone: insight from the Borgou population. Mol. Ecol. 2014, 23:3241-3257.
13. Bouyer J., et al. Community- and farmer-based management of animal African trypanosomosis in cattle. Trends Parasitol. 2013, 29:519-522.
14. Hanotte O., et al. Mapping of quantitative trait loci controlling trypanotolerance in a cross of tolerant West African N'Dama and susceptible East African Boran cattle. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7443-7448.
15. Hanotte O., et al. Ecology. Time to tap Africa's livestock genomes. Science 2010, 328:1640-1641.
16. Pays E., et al. The molecular arms race between African trypanosomes and humans. Nat. Rev. Microbiol. 2014, 12:575-584.
17. Control and Surveillance of Human African Trypanosomiasis 2013, World Health Organization, World Health Organization. 984 edn.
18. Franco J.R., et al. Epidemiology of human African trypanosomiasis. Clin. Epidemiol. 2014, 6:257-275.
19. Brun R., et al. Human African trypanosomiasis. Lancet 2010, 375:148-159.
20. Jamonneau V., et al. Untreated infections by Trypanosoma brucei gambiense are not 100% fatal. PLoS Negl. Trop. Dis. 2012, 6:e1691.
21. Sudarshi D., et al. Human African trypanosomiasis presenting at least 29 years after infection - what can this teach us about the pathogenesis and control of this neglected tropical disease?. PLoS Negl. Trop. Dis. 2014, 8:e3349.
22. Ilboudo H., et al. Diversity of response to Trypanosoma brucei gambiense infections in the Forecariah mangrove focus (Guinea): perspectives for a better control of sleeping sickness. Microbes Infect. 2011, 13:943-952.
23. Garcia A., et al. Follow-up of card agglutination trypanosomiasis test (CATT) positive but apparently aparasitemic individuals in Côte d'Ivoire: evidence for a complex and heterogeneous population. Trop. Med. Int. Health 2000, 5:786-793.
24. Franco J.R., et al. The journey towards elimination of gambiense human African trypanosomiasis: not far, nor easy. Parasitology 2014, 141:748-760.
25. Solano P., et al. Is vector control needed to eliminate gambiense human African trypanosomiasis?. Front. Cell Infect. Microbiol. 2013, 3:33.
26. Courtin F., et al. Reducing human-tsetse contact significantly enhances the efficacy of sleeping sickness active screening campaigns: a promising result in the context of elimination. PLoS Negl. Trop. Dis. 2015, 12:e0003727.
27. Southgate B.A., Manson-Bahr P.E. Studies in the epidemiology of East African leishmaniasis. 4. The significance of the positive leishmanin test. J. Trop. Med. Hyg. 1967, 70:29-33.
28. Pampiglione S., et al. Studies on Mediterranean leishmaniasis. 2. Asymptomatic cases of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 1974, 68:447-453.
29. Badaro R., et al. New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 1986, 154:1003-1011.
30. Ashford R.W. The leishmaniases as emerging and reemerging zoonoses. Int. J. Parasitol. 2000, 30:1269-1281.
31. Le Fichoux Y., et al. Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J. Clin. Microbiol. 1999, 37:1953-1957.
32. Marty P., et al. Use of the leishmanin skin test and Western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in a highly endemic focus in Alpes-Maritimes (France). Trans. R. Soc. Trop. Med. Hyg. 1994, 88:658-659.
33. Riera C., et al. Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Islands, Spain) by different diagnostic methods. Trans. R. Soc. Trop. Med. Hyg. 2004, 98:102-110.
34. Barao S.C., et al. Human asymptomatic infection in visceral leishmaniasis: a seroprevalence study in an urban area of low endemicity. Preliminary results. Am. J. Trop. Med. Hyg. 2007, 77:1051-1053.
35. Solano-Gallego L., et al. LeishVet guidelines for the practical management of canine leishmaniosis. Parasit. Vectors 2011, 4:86.
36. Miro G., et al. Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part two. Trends Parasitol. 2008, 24:371-377.
37. Berrahal F., et al. Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting. Am. J. Trop. Med. Hyg. 1996, 55:273-277.
38. Papadopoulou C., et al. Human and canine leishmaniasis in asymptomatic and symptomatic population in Northwestern Greece. J. Infect. 2005, 50:53-60.
39. Queiroz P.V., et al. Canine visceral leishmaniasis in urban and rural areas of Northeast Brazil. Res. Vet. Sci. 2009, 86:267-273.
40. Hasker E., et al. Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal. PLoS Negl. Trop. Dis. 2014, 8:e2657.
41. Cunningham J., et al. A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin. Infect. Dis. 2012, 55:1312-1319.
42. Boelaert M., et al. Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease. Cochrane Database Syst. Rev. 2014, 6:CD009135.
43. de Ruiter C.M., et al. Molecular tools for diagnosis of visceral leishmaniasis: systematic review and meta-analysis of diagnostic test accuracy. J. Clin. Microbiol. 2014, 52:3147-3155.
44. Ahmed B-N., et al. Kala-azar (visceral leishmaniasis) elimination in Bangladesh: successes and challenges. Curr. Trop. Med. Rep. 2014, 1:163-169.
45. Matlashewski G., et al. Visceral leishmaniasis: elimination with existing interventions. Lancet Infect. Dis. 2011, 11:322-325.
46. Warburg A., Faiman R. Research priorities for the control of phlebotomine sand flies. J. Vector Ecol. 2011, 36:S10-S16.
47. Palatnik-de-Sousa C.B. Vaccines for canine leishmaniasis. Front. Immunol. 2012, 3:69.
48. Lemesre, J-L. (1993) Procédé de culture in vitro de différents stades de parasites tissulaires obtenus et applications biologiques, FR2705358A1.
49. Holzmuller P., et al. Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis. Vet. Immunol. Immunopathol. 2005, 106:247-257.
50. Lemesre J-L., et al. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 2005, 23:2825-2840.
51. Lemesre J-L., et al. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Vaccine 2007, 25:4223-4234.
52. Bourdoiseau G., et al. Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs. Vet. Immunol. Immunopathol. 2009, 128:71-78.
53. ®) remains effective against an experimental challenge one year later. Vet. Res. 2014, 45:69.
54. ®) reduces the intensity of infection in Phlebotomus perniciosus fed on Leishmania infantum infected dogs - a preliminary xenodiagnosis study. Vet. Parasitol. 2013, 197:691-695.
55. Rock K.S., et al. Uniting mathematics and biology for control of visceral leishmaniasis. Trends Parasitol. 2015, 31:251-259.
56. Hontebeyrie M., et al. Pathological consequences of host response to parasite. American trypanosomiasis. Chagas Disease One Hundred Years of Research 2010, 669-690. Elsevier. J. Telleria, M. Tibayrenc (Eds.).
57. Coura J.R. Chagas disease: what is known and what is needed - a background article. Mem. Inst. Oswaldo Cruz 2007, 102(Suppl. 1):113-122.
58. Andrade Z.A., et al. The indeterminate phase of Chagas' disease: ultrastructural characterization of cardiac changes in the canine model. Am. J. Trop. Med. Hyg. 1997, 57:328-336.
59. Polley L. Navigating parasite webs and parasite flow: emerging and re-emerging parasitic zoonoses of wildlife origin. Int. J. Parasitol. 2005, 35:1279-1294.
60. Gurtler R.E., et al. Influence of humans and domestic animals on the household prevalence of Trypanosoma cruzi in Triatoma infestans populations in northwest Argentina. Am. J. Trop. Med. Hyg. 1998, 58:748-758.
61. Cominetti M.C., et al. Epidemiological factors related to the transmission risk of Trypanosoma cruzi in a Quilombola community, State of Mato Grosso do Sul, Brazil. Rev. Soc. Bras. Med. Trop. 2011, 44:576-581.
62. Bern C. Chagas' disease. N. Engl. J. Med. 2015, 373:456-466.
63. Ayo C.M., et al. Genetic susceptibility to Chagas disease: an overview about the infection and about the association between disease and the immune response genes. Biomed. Res. Int. 2013, 2013:284729.
64. Schofield C.J., et al. The future of Chagas disease control. Trends Parasitol. 2006, 22:583-588.
65. van der Waaij E.H., et al. Population parameters for traits defining trypanotolerance in an F2 cross of N'Dama and Boran cattle. Livestock Prod. Sci. 2003, 84:219-230.
66. Noyes H., et al. Genetic and expression analysis of cattle identifies candidate genes in pathways responding to Trypanosoma congolense infection. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9304-9309.
67. Gautier M., et al. A whole genome Bayesian scan for adaptive genetic divergence in West African cattle. BMC Genomics 2009, 10:550.
68. Dayo G.K., et al. Detection of selection signatures within candidate regions underlying trypanotolerance in outbred cattle populations. Mol. Ecol. 2009, 18:1801-1813.
69. Kemp S.J., et al. Localization of genes controlling resistance to trypanosomiasis in mice. Nat. Genet. 1997, 16:194-196.
70. Nganga J.K., et al. High resolution mapping of trypanosomosis resistance loci Tir2 and Tir3 using F12 advanced intercross lines with major locus Tir1 fixed for the susceptible allele. BMC Genomics 2010, 11:394.
71. Goodhead I., et al. A comprehensive genetic analysis of candidate genes regulating response to Trypanosoma congolense infection in mice. PLoS Negl. Trop. Dis. 2010, 4:e880.
72. Courtin D., et al. Host genetics in African trypanosomiasis. Infect. Genet. Evol. 2008, 8:229-238.
73. Bucheton B., et al. Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections. Parasite Immunol. 2011, 33:438-447.
74. Courtin D., et al. Interest of tumor necrosis factor-α-308 G/A and interleukin-10-592 C/A polymorphisms in human African trypanosomiasis. Infect. Genet. Evol. 2006, 6:123-129.
75. Courtin D., et al. Association between human African trypanosomiasis and the IL6 gene in a Congolese population. Infect. Genet. Evol. 2007, 7:60-68.
76. Courtin D., et al. HLA-G 3' UTR-2 haplotype is associated with human African trypanosomiasis susceptibility. Infect. Genet. Evol. 2013, 17:1-7.
77. Genovese G., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329:841-845.
78. Ibrahim M.E., et al. Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am. J. Trop. Med. Hyg. 1999, 61:941-944.
79. Bucheton B., et al. The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes Infect. 2002, 4:1449-1457.
80. Blackwell J.M. Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 1996, 112(Suppl.):S67-S74.
81. Bucheton B., et al. Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region. Genes Immun. 2003, 4:104-109.
82. Bucheton B., et al. A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. Am. J. Hum. Genet. 2003, 73:1052-1060.
83. Bucheton B., et al. Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis. Genes Immun. 2007, 8:79-83.
84. Oliveira P.R., et al. IL2RA genetic variants reduce IL-2-dependent responses and aggravate human cutaneous leishmaniasis. J. Immunol. 2015, 194:2664-2672.
85. Samanovic M., et al. Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection. PLoS Pathog. 2009, 5:e1000276.
86. Fakiola M., et al. Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. Nat. Genet. 2013, 45:208-213.
87. Zicker F., et al. Physical activity, opportunity for reinfection, and sibling history of heart disease as risk factors for Chagas' cardiopathy. Am. J. Trop. Med. Hyg. 1990, 43:498-505.
88. Cunha-Neto E., Chevillard C. Chagas disease cardiomyopathy: immunopathology and genetics. Mediators Inflamm. 2014, 2014:683230.
89. Frade A.F., et al. Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways. BMC Infect. Dis. 2013, 13:587.
90. Deng X., et al. Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects. PLoS ONE 2013, 8:e79629.
91. Michalsky E.M., et al. Infectivity of seropositive dogs, showing different clinical forms of leishmaniasis, to Lutzomyia longipalpis phlebotomine sand flies. Vet. Parasitol. 2007, 147:67-76.
92. Wombou Toukam C.M., et al. Experimental evaluation of xenodiagnosis to detect trypanosomes at low parasitaemia levels in infected hosts. Parasite 2011, 18:295-302.
93. Van den Bossche P., et al. Transmissibility of Trypanosoma brucei during its development in cattle. Trop. Med. Int. Health 2005, 10:833-839.
94. Payne W.J.A., Hodges J. Tropical Cattle: Origins and Breeding Policies 1997, Blackwell Science.
95. Felius M., et al. On the history of cattle genetic resources. Diversity 2014, 6:705-750.
96. Dayo G.K., et al. Association studies in QTL regions linked to bovine trypanotolerance in a West African crossbred population. Anim. Genet. 2012, 43:123-132.
97. Berthier D., et al. Serial analysis of gene expression (SAGE) in bovine trypanotolerance: preliminary results. Genet. Sel. Evol. 2003, 35(Suppl. 1):S35-S47.
98. Berthier D., et al. Bovine transcriptome analysis by SAGE technology during an experimental Trypanosoma congolense infection. Ann. N. Y. Acad. Sci. 2006, 1081:286-299.
99. Berthier D., et al. Study of bovine trypanotolerance by whole transcriptome analysis. Ann. N. Y. Acad. Sci. 2008, 1149:71-76.
100. O'Gorman G.M., et al. Transcriptional profiling of cattle infected with Trypanosoma congolense highlights gene expression signatures underlying trypanotolerance and trypanosusceptibility. BMC Genomics 2009, 10:207.